Intermediate clinical endpoints (ICE) as potential surrogates for overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC) Meeting Abstract
| Authors: | Halabi, S.; Roy, A.; Rydzewska, L.; Godolphin, P.; Parmar, M. K.; Hussain, M.; Tangen, C.; Thompson, I. M.; Xie, W.; Carducci, M. A.; Smith, M.; Morris, M. J.; Mescam, G. G.; Dearnaley, D.; Verhagen, P.; Goto, T.; James, N. D.; Buyse, M. E.; Tierney, J.; Sweeney, C. J. |
| Abstract Title: | Intermediate clinical endpoints (ICE) as potential surrogates for overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC) |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1171 |
| Language: | English |
| ACCESSION: | WOS:000866211601632 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.annonc.2022.07.1507 |
| Notes: | Meeting Abstract: 1375P -- Source: Wos |
